Jinming Yu

机构：Shandong University, Beijing Technology and Business University, Southwest Medical University, Wuhan University, Affiliated Hospital of Southwest Medical University, Shandong Tumor Hospital, The People's Hospital of Guangxi Zhuang Autonomous Region, Renmin Hospital of Wuhan University, Shandong First Medical University · ORCID：0000-0001-7710-5466

发表论文 120 篇 · 总被引 3400 次 · h-index 23

代表论文

• Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial (2024 · EClinicalMedicine · 被引 37)
• Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases (2024 · Cancer Letters · 被引 18)
• PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR) (2024 · Journal of Thoracic Oncology · 被引 17)
• Deciphering the role of immunoglobulin secreting malignant lineages in the invasive frontiers of small cell lung cancer by scRNA-seq and spatial transcriptomics analysis (2023 · Cell Discovery · 被引 16)
• Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progression (2024 · BMC Cancer · 被引 13)
• Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3/cAMP/PKA pathway (2024 · Reproductive Biology and Endocrinology · 被引 11)